Magnetizable solid-phase supports for purification of nucleic acids
Bruce, I J, Davies, M J, Howard, K, Smethurst, D E, Todd, M
Published in Journal of pharmacy and pharmacology (01.02.1996)
Published in Journal of pharmacy and pharmacology (01.02.1996)
Get more information
Journal Article
Improved manufacture and application of an agarose magnetizable solid-phase support
DAVIES, M. J, SMETHURST, D. E, HOWARD, K. M, TODD, M, HIGGINS, L. M, BRUCE, I. J
Published in Applied biochemistry and biotechnology (01.10.1997)
Published in Applied biochemistry and biotechnology (01.10.1997)
Get full text
Journal Article
MA03.06 Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC
Felip, E., Brunsvig, P., Helland, Å., Viñolas, N., Aix, S., Carcereny, E., Gomez, M. Dómine, Perez, J.M. Trigo, Arriola, E., Campelo, R. Garcia, Spicer, J., Thompson, J., Granados, A.L. Ortega, Holt, R., Smethurst, D., Lorens, J., Shoaib, M., Siddiqui, A., Schoelermann, J., Lorens, K., Schmidt, E., Chisamore, M.J., Krebs, M.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
P1.01-72 A Phase II Study of Selective AXL Inhibitor Bemcentinib and Pembrolizumab in Patients with NSCLC Refractory to Anti-PD(L)1
Krebs, M., Brunsvig, P., Helland, Å., Viñolas, N., Aix, S., Carcereny, E., Gomez, M. Dómine, Perez, J.M. Trigo, Arriola, E., Campelo, R. Garcia, Spicer, J., Thompson, J., Granados, A.L. Ortega, Holt, R., Smethurst, D., Lorens, J., Shoaib, M., Siddiqui, A., Schoelermann, J., Lorens, K., Schmidt, E., Chisamore, M.J., Felip, E.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
A randomized, phase I/II trial of AMG 102 or AMG 479 in combination with panitumumab (pmab) compared with pmab alone in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC): Safety and efficacy results
Van Cutsem, E., Eng, C., Tabernero, J., Nowara, E., Swieboda-Sadlej, A., Tebbutt, N. C., Mitchell, E. P., Davidenko, I., Chen, L., Smethurst, D.
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
A randomized, phase Ib/II trial of rilotumumab (AMG 102; ril) or ganitumab (AMG 479; gan) with panitumumab (pmab) versus pmab alone in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC): Primary and biomarker analyses
Eng, C., Van Cutsem, E., Nowara, E., Swieboda-Sadlej, A., Tebbutt, N. C., Mitchell, E. P., Davidenko, I., Oliner, K., Chen, L., Huang, J., McCaffery, I., Loh, E., Smethurst, D., Tabernero, J.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Panitumumab (pmab) plus AMG 102 in patients (pts) with wild-type KRAS metastatic colorectal cancer (mCRC): Updated safety results
Eng, C., Tabernero, J., Nowara, E., Swieboda-Sadlej, A., Tebbutt, N. C., Mitchell, E. P., Davidenko, I., Chen, L., Smethurst, D., Van Cutsem, E.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A randomized phase II study of paclitaxel (P) and carboplatin (C) ± bevacizumab (B) ± dulanermin (D) in non-small cell lung cancer (NSCLC)
Blackhall, F. H., Márk, Z., Zatloukal, P., Szima, B., Albert, I., Juhász, E., Yang, X., Smethurst, D., Hei, Y., Soria, J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A best in class anti-CD38 antibody with antitumor and immune-modulatory properties
Eissler, N, Filosto, S, Henry, JY, Maguire, MF, Witt, K, Lundqvist, A, Marafioti, T, Merchiers, P, Moulder, K, Goyenechea, B, Lu, H, Fairbairn, C, Windler, S, Aurellano, JD, Duramad, O, Smethurst, D, Quezada, SA, Goubier, A
Published in CANCER RESEARCH (2018)
Published in CANCER RESEARCH (2018)
Get full text
Conference Proceeding
A phase Ib/II trial of AMG 655 and panitumumab (pmab) for the treatment (tx) of metastatic colorectal cancer (mCRC): Safety results
Rougier, P., Infante, J., Van Laethem, J., Stephenson, J. J., Uronis, H., Schwartzberg, L., Chen, L., Wu, C., Smethurst, D., Peeters, M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article